- Home
- TLSA vs SY Comparison
TLSA vs SY Comparison
Compare TLSA & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- SY
- Stock Information
- Founded
- TLSA 2013
- SY 2013
- Country
- TLSA United Kingdom
- SY China
- Employees
- TLSA N/A
- SY N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- SY EDP Services
- Sector
- TLSA Health Care
- SY Technology
- Exchange
- TLSA Nasdaq
- SY Nasdaq
- Market Cap
- TLSA 187.0M
- SY 482.1M
- IPO Year
- TLSA 2000
- SY 2019
- Fundamental
- Price
- TLSA $1.78
- SY $3.81
- Analyst Decision
- TLSA
- SY Strong Buy
- Analyst Count
- TLSA 0
- SY 1
- Target Price
- TLSA N/A
- SY $5.50
- AVG Volume (30 Days)
- TLSA 330.7K
- SY 1.2M
- Earning Date
- TLSA 05-06-2025
- SY 08-15-2025
- Dividend Yield
- TLSA N/A
- SY 0.70%
- EPS Growth
- TLSA N/A
- SY N/A
- EPS
- TLSA N/A
- SY N/A
- Revenue
- TLSA N/A
- SY $197,807,588.00
- Revenue This Year
- TLSA N/A
- SY $8.61
- Revenue Next Year
- TLSA N/A
- SY $54.55
- P/E Ratio
- TLSA N/A
- SY N/A
- Revenue Growth
- TLSA N/A
- SY N/A
- 52 Week Low
- TLSA $0.63
- SY $0.66
- 52 Week High
- TLSA $2.60
- SY $6.28
- Technical
- Relative Strength Index (RSI)
- TLSA 49.08
- SY 46.57
- Support Level
- TLSA $1.63
- SY $3.63
- Resistance Level
- TLSA $1.88
- SY $4.15
- Average True Range (ATR)
- TLSA 0.16
- SY 0.27
- MACD
- TLSA -0.00
- SY 0.01
- Stochastic Oscillator
- TLSA 69.23
- SY 56.05
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About SY So-Young International Inc. American Depository Shares
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.